The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Results of a phase II trial of neoadjuvant abiraterone + prednisone+ enzalutamide + leuprolide (APEL) versus enzalutamide + leuprolide (EL) for patients with high-risk localized prostate cancer (PC) undergoing radical prostatectomy (RP).
 
Rana R. McKay
Research Funding - Bayer (Inst); Pfizer (Inst)
 
Wanling Xie
Consulting or Advisory Role - Bayer
 
Rosina Lis
No Relationships to Disclose
 
Huihui Ye
No Relationships to Disclose
 
Zhenwei Zhang
No Relationships to Disclose
 
Quoc-Dien Trinh
No Relationships to Disclose
 
Steven Lee Chang
No Relationships to Disclose
 
Lauren Christine Harshman
Consulting or Advisory Role - Corvus Pharmaceuticals; Dendreon; Genentech; KEW; Medivation/Astellas; Merck; NCCN; Pfizer; PlatformQ Health; Theragene
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); Medivation/Astellas (Inst); Merck (Inst); Sotio (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Bayer
 
Ashley Ross
Stock and Other Ownership Interests - GenomeDx
Honoraria - Healthtronics
Consulting or Advisory Role - Healthtronics
Research Funding - metamark genetics
 
Kenneth J. Pienta
Leadership - Curis
Honoraria - Johnson & Johnson
Research Funding - Celsee Diagnostics; Johnson & Johnson (Inst)
 
Daniel W. Lin
Consulting or Advisory Role - Astellas Pharma
Research Funding - GenomeDx (Inst); Genomic Health (Inst); MDxHealth (Inst)
 
William J Ellis
No Relationships to Disclose
 
Robert B. Montgomery
Research Funding - ESSA; Ferring; Janssen Oncology; Medivation/Astellas
 
Peter Chang
No Relationships to Disclose
 
Andrew Wagner
No Relationships to Disclose
 
Glenn Bubley
No Relationships to Disclose
 
Adam S. Kibel
No Relationships to Disclose
 
Mary-Ellen Taplin
Honoraria - Bayer; Clovis Oncology; Janssen-Ortho; Medivation
Consulting or Advisory Role - Bayer; Best Doctors, Inc; Clovis Oncology; Dava Oncology; Guidepoint Global; Janssen-Ortho; Medivation; Myovant Sciences; Research to Practice; Sanofi; UpToDate
Research Funding - Bayer (Inst); Genentech (Inst); Janssen-Ortho (Inst); Medivation (Inst); Tokai Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Janssen Oncology; Medivation; Tokai Pharmaceuticals